Brain-derived neurotrophic factor

N/A

Report date: 2024/12/18 10:01:29

Base Information

Drug NameBrain-derived neurotrophic factor
Drug Alias NameBDNFBrain-derived growth factor
ClassificationBiologics > Protein drugs > Non-recombinant cytokines
Mechanisms of ActionNeurotrophic tyrosine kinase receptor type 2 stimulantsNerve growth factor receptors antagonists
TargetsNeurotrophic tyrosine kinase receptor type 2Nerve growth factor receptors
Therapy Area/IndicationsAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMax-Planck-Institute Of Experimental Medicine
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSumitomo DainipponMax-Planck-Institute Of Experimental MedicineAmgen Inc +[4] 
Active IndicationsN/A
Inactive IndicationsAmyotrophic Lateral Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A